236
Views
1
CrossRef citations to date
0
Altmetric
PRECONCEPTION GENETIC TESTING IN 21-HYDROXYLASE CAH

The importance and implications of preconception genetic testing for accurate fetal risk estimation in 21-hydroxylase congenital adrenal hyperplasia (CAH)

ORCID Icon &
Pages 28-31 | Received 29 Jul 2017, Accepted 14 Jun 2018, Published online: 25 Jul 2018

References

  • Speiser P, Azziz R, Baskin L, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:4133–60.
  • New M, Abraham M, Gonzalez B, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA. 2013;110:2611–6.
  • Nimkarn S, Gangishetti PK, Yau M, et al. 21-Hydroxylase-deficient congenital adrenal hyperplasia. In: Pagon RA, Adam MP, Ardinger HH, et al. editors. GeneReviews®. Seattle (WA): University of Washington; 1993. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1171/.
  • Ezquieta B, Alonso M, Alvarez E, et al. Should 21-hydroxylase deficiency genotyping be considered in assisted reproductive technology programs? Fertil Steril. 2007;88:1437.e5–11.
  • Fernández-Balsells MM, Muthusamy K, Smushkin G, et al. Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses. Clin Endocrinol (Oxf.) 2010;73:no–444.
  • Wedell A, Luthman H. Steroid 21-hydroxylase (P450c21): a new allele and spread of mutations through the pseudogene. Hum Genet. 1993;91:236–40.
  • Schouten J, McElgunn C, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002;30. Available at: http://www.ncbi.nlm.nih.gov/pubmed/?term=Schouten+JP+et+al.+(2002)+Relative+quantification+of+40+nucleic+acid+sequences+by+multiplex+ligationdependent+probe+amplification+Nucleic+Acids+Res+30%2C+e57.
  • White P, Speiser P. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21:245–91.
  • Sharp R, Foster M. Clinical utility and full disclosure of genetic results to research participants. Am J Bioeth. 2006;6:42–4.
  • Dreger A, Feder E, Tamar-Mattis A. Prenatal dexamethasone for congenital adrenal hyperplasia: an ethics canary in the modern medical mine. J Bioethical Inq. 2012;9:277–94.
  • Nimkarn S, New M. Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Nat Rev Endocrinol. 2007;3:405–13.
  • Forest M. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod Update. 2004;10:469–85.
  • Lajic S, Nordenström A, Hirvikoski T. Long-term outcome of prenatal treatment of congenital adrenal hyperplasia. Endocrinol Dev. 2008;13:82–98.
  • Joint LWPES/ESPE CAH Working Group. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab. 2002;87:4048–53.
  • Wah YM, Leung TY, Cheng YKY, et al. Procedure-related fetal loss following chorionic villus sampling after first-trimester aneuploidy screening. Fetal Diagn Ther. 2017;41:184–90.
  • New M, Tong Y, Yuen T, et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab. 2014;99:E1022–30.
  • Tardy-Guidollet V, Menassa R, Costa J, et al. New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002–2011). J Clin Endocrinol Metab. 2014;99:1180–8.
  • Bustamante-Aragonés A, Rodríguez de Alba M, Perlado S, et al. Non-invasive prenatal diagnosis of single-gene disorders from maternal blood. Gene. 2012;504:144–9.
  • Mackie FL, Hemming K, Allen S, et al. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG Int J Obstet Gynaecol. 2017;124:32–46.
  • Grace J, El T, Braude P. Pre-implantation genetic testing. BJOG Int J Obstet Gynaecol. 2004;111:1165–73.
  • Brezina P, Kutteh W. Clinical applications of preimplantation genetic testing. BMJ. 2015;350:g7611.
  • Harton G, Magli M, Lundin K, et al. ESHRE PGD consortium/embryology special interest group – best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod Oxf Engl. 2011;26:41–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.